Regulus Therapeutics Inc.

NASDAQ:RGLS

1.49 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q3
Revenue 000.302000000000005500.0060.0180.0180.0186.7780.0180.0180.0180.0180.0180.0180.0180.0180.0180.2040.4830.48910.861.8653.8344.24.2191.0830.7361.6315.4546.1184.7593.2383.2382.8093.3093.3443.3633.809
Cost of Revenue 0.0890.0810.0760.0560.0470.0480.0330.0320.0310.0264.4090.0380.0450.3353.9514.0364.2423.1192.092.441.8365.9835.2866.84810.01311.82810.46512.69715.67715.75214.97914.55418.00716.76412.79410.96517.90113.42710.47410.17310.7959.6048.2327.1067.7220.0070.0060.0050000
Gross Profit -0.089-0.0810.226-0.056-0.047-0.048-0.033-0.032-0.031-0.026-4.409-0.038-0.045-0.3351.0490.964-4.242-3.113-2.072-2.422-1.8180.795-5.268-6.83-9.995-11.81-10.447-12.679-15.659-15.734-14.961-14.35-17.524-16.275-1.934-9.1-14.067-9.227-6.255-9.09-10.059-7.973-2.778-0.988-2.9633.2313.2322.8043.3093.3443.3633.809
Gross Profit Ratio 000.748000000000000.210.1930-518.833-115.111-134.556-1010.117-292.667-379.444-555.278-656.111-580.389-704.389-869.944-874.111-831.167-70.343-36.282-33.282-0.178-4.879-3.669-2.197-1.483-8.393-13.667-4.888-0.509-0.161-0.6230.9980.9980.9981111
Reseach & Development Expenses 8.246.045.7075.4884.9764.9254.7135.314.7083.6794.4095.9154.153.323.9514.0364.2423.1192.092.441.8365.9835.2556.87910.01311.82810.46512.69714.27815.75214.97914.55418.00716.76412.79410.96519.20113.42710.47410.17310.7959.6048.2327.1067.7226.8835.6075.2484.8834.6034.4663.875
General & Administrative Expenses 3.9512.7862.5372.6372.3392.4442.2192.2532.4672.892.5512.5042.4882.4782.0782.0592.2542.4222.3632.5712.853.5332.7452.9933.3493.7733.2592.7367.0573.9594.7834.8423.6645.1035.4274.2455.8143.6443.2782.5692.9542.7321.8841.9171.7231.9051.9341.0930.9840.92100.907
Selling & Marketing Expenses -0.020-0.020000000000000000000000000000000000000000000000000
SG&A 3.9312.7862.5172.6372.3392.4442.2192.2532.4672.892.5512.5042.4882.4782.0782.0592.2542.4222.3632.5712.853.5332.7452.9933.3493.7733.2592.7367.0573.9594.7834.8423.6645.1035.4274.2455.8143.6443.2782.5692.9542.7321.8841.9171.7231.9051.9341.0930.9840.9210.7730.907
Other Expenses -8.309000000.137000-0.17300-0.215-0.286000-0.458000-0.5200000000000000000000000000000
Operating Expenses 12.1718.8268.2248.1257.3157.3696.9327.5637.1756.5696.968.4196.6385.7986.0296.0956.4965.5414.4535.0114.6869.51689.87213.36215.60113.72415.43321.33519.71119.76219.39621.67121.86718.22115.2125.01517.07113.75212.74213.74912.33610.1169.0239.4458.7887.5416.3415.8675.5245.2394.782
Operating Income -12.26-8.826-8.3-8.125-7.315-7.369-6.932-7.563-7.175-6.569-6.96-8.419-6.638-5.798-1.029-1.095-6.496-5.535-4.435-4.993-4.668-2.738-7.982-9.854-13.344-15.583-13.706-15.415-21.317-19.693-19.744-19.192-21.188-21.378-7.361-13.345-21.181-12.871-9.533-11.659-13.013-10.705-4.662-2.905-4.686-5.55-4.303-3.532-2.558-2.18-1.876-0.973
Operating Income Ratio 00-27.48300000000000-0.206-0.2190-922.5-246.389-277.389-259.333-0.404-443.444-547.444-741.333-865.722-761.444-856.389-1,184.278-1,094.056-1,096.889-94.078-43.867-43.718-0.678-7.155-5.525-3.065-2.26-10.765-17.681-6.563-0.855-0.475-0.985-1.714-1.329-1.257-0.773-0.652-0.558-0.255
Total Other Income Expenses Net 1.2250.3570.2390.3010.3030.230.1370.012-0.083-0.149-0.173-0.2090.605-0.215-0.286-0.428-0.451-0.41-0.458-0.43-0.347-0.522-0.52-0.419-0.503-0.441-0.8-0.42-0.419-0.332-0.271-0.3230.090.1660.1390.3290.144-1.811-12.6351.8610.953-2.1242.7160.736-2.652-1.689-2.638-2.069-0.063-0.066-0.0010.001
Income Before Tax -11.035-8.469-8.061-7.824-7.012-7.139-6.795-7.551-7.258-6.718-7.133-8.628-6.033-6.013-1.315-1.523-6.947-5.945-4.893-5.423-5.015-3.26-8.502-10.273-13.847-16.024-14.506-15.835-21.736-20.025-20.015-19.515-21.098-21.212-7.222-13.016-21.037-14.491-22.168-9.798-11.973-12.74-1.946-2.169-7.338-7.239-6.858-5.691-2.621-2.246-1.94-1.041
Income Before Tax Ratio 00-26.69200000000000-0.263-0.3050-990.833-271.833-301.278-278.611-0.481-472.333-570.722-769.278-890.222-805.889-879.722-1,207.556-1,112.5-1,111.944-95.662-43.681-43.378-0.665-6.979-5.487-3.45-5.254-9.047-16.268-7.811-0.357-0.355-1.542-2.236-2.118-2.026-0.792-0.672-0.577-0.273
Income Tax Expense 0.001-0.0810.1-0.0560.001-0.0450.001-0.0120.0830.0010.2140.0010.001-0.3350.0070.0010.01-0.008-0.1310.0870.0010.0560.0610.2010.1180.001-0.058-0.007-0.128-0.0040.0050.004-0.008-0.0050.004-0.016-0.002-0.004-0.001-2.2590.010.001-0.019-0.0050.01-0.010.018-0.006-0.0220.0010.0750.004
Net Income -11.036-8.469-8.061-7.824-7.013-7.094-6.796-7.539-7.341-6.719-7.133-8.628-6.034-6.013-1.322-1.524-6.947-5.937-4.893-5.423-5.016-3.26-8.563-10.273-13.847-16.025-14.448-15.828-21.608-20.021-20.02-19.519-21.09-21.207-7.226-13-21.035-14.487-22.168-9.798-11.973-12.741-1.927-2.164-7.348-7.229-6.876-5.685-2.599-2.247-2.015-1.045
Net Income Ratio 00-26.69200000000000-0.264-0.3050-989.5-271.833-301.278-278.667-0.481-475.722-570.722-769.278-890.278-802.667-879.333-1,200.444-1,112.278-1,112.222-95.681-43.665-43.368-0.665-6.971-5.486-3.449-5.254-9.047-16.268-7.812-0.353-0.354-1.544-2.233-2.124-2.024-0.785-0.672-0.599-0.274
EPS -0.17-0.29-0.4-0.4-0.37-0.42-0.4-0.5-0.5-0.46-0.67-0.99-0.78-0.84-0.28-0.4-2.33-2.47-2.34-2.6-3-3.14-9.75-11.8-15.93-18.49-16.68-21.09-48.76-45.34-45.39-44.33-47.95-48.28-16.52-30.01-49.42-34.72-56.76-27.09-33.13-35.81-5.53-6.47-24.5-24.18-23.03-1,918.02-1,293.03-1,568.04-2,704.7-352.56
EPS Diluted -0.17-0.29-0.4-0.4-0.37-0.42-0.4-0.5-0.5-0.46-0.67-0.99-0.78-0.84-0.28-0.4-2.33-2.47-2.34-2.6-3-3.14-9.75-11.8-15.93-18.49-16.68-21.09-48.76-45.34-45.39-44.33-47.95-48.28-16.52-30.01-49.42-34.72-56.76-26.21-32.07-35.81-5.35-6.25-24.5-24.18-23-1,918.02-1,293.03-1,568.04-2,704.7-352.56
EBITDA -12.171-8.826-8.224-8.125-6.797-6.906-6.932-7.344-7.065-6.537-6.96-8.38-5.772-5.798-1.029-0.943-6.364-5.33-4.435-4.779-4.306-2.18-7.982-9.102-12.668-14.856-12.906-14.67-20.475-18.78-19.473-18.869-21.278-20.769-7.5-12.631-21.325-12.2783.102-13.52-12.57-10.251-7.378-3.641-2.034-3.861-3.991-3.252-2.275-1.928-1.589-0.718
EBITDA Ratio 00-27.23200000000000-0.206-0.1890-888.333-246.389-265.5-239.222-0.322-443.444-505.667-703.778-825.333-717-815-1,137.5-1,043.333-1,081.833-92.495-44.054-42.472-0.691-6.773-5.562-2.9230.735-12.484-17.079-6.285-1.353-0.595-0.427-1.192-1.233-1.158-0.688-0.577-0.472-0.189